Company intelligence / Profile preview

Via Scientific

Cambridge, Massachusetts, United Statesviascientific.com ↗

Ownership: Private
Development stage: Other

Overview

Via Scientific offers the Foundry platform—a cloud-based multi‑omics analytics solution designed to automate complex bioinformatics workflows for scientists in biotech/pharma R&D and academia. The technology enables rapid analysis of large-scale biological datasets with no-code interfaces as well as advanced AI-driven features. The company has secured $5M in seed funding to accelerate go-to-market activities and expand its technology offering. It does not develop therapeutics or diagnostics itself but empowers those who do with advanced informatics tools.

Industry: Drug Discovery Services

Partnerships

No major pharma/biotech partnerships publicly disclosed as of June 2025; collaborates broadly with academic institutions and industry clients using its platform

Beyond the preview

Go deeper on Via Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Via Scientific.

Explore the full profile